Overview
Michael Bar is a Hematologist in Stamford, Connecticut. Dr. Bar is highly rated in 39 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Small Lymphocytic Lymphoma (SLL).
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Hospital Plz, Stamford, CT 06902
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist in New York, New York. Dr. Moskowitz is highly rated in 32 conditions, according to our data. Her top areas of expertise are T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Gilles Salles is a Hematologist and an Oncologist in New York, New York. Dr. Salles is highly rated in 27 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Transplant, and Splenectomy. Dr. Salles is currently accepting new patients.
Montefiore Medical Center
Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is highly rated in 25 conditions, according to our data. Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Michael Bar
How do I make an appointment with Dr. Michael Bar?
You can book an appointment with Dr. Michael Bar by calling their office at 203-276-2695. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michael Bar a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael Bar is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michael Bar specialize in?
While Dr. Michael Bar is a Hematology, they have specific expertise in Multiple Myeloma, Schnitzler Syndrome, and Monoclonal Gammopathy of Undetermined Significance (MGUS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Michael Bar participate in research or clinical trials?
Yes. Dr. Michael Bar has published 1 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Michael Bar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michael Bar accept my insurance?
Dr. Michael Bar accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 203-276-2695 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Dr. Bar isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Bar isDistinguished. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaDr. Bar isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Schnitzler SyndromeDr. Bar isDistinguished. Learn about Schnitzler Syndrome.
- Advanced
- Acute Eosinophilic Pneumonia
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Adult Immune Thrombocytopenia
- Antiphospholipid SyndromeDr. Bar isAdvanced. Learn about Antiphospholipid Syndrome.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Acute Promyelocytic LeukemiaDr. Bar isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Bar isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Anaplastic Large Cell LymphomaDr. Bar isExperienced. Learn about Anaplastic Large Cell Lymphoma.